Diva Laboratories, Ltd.(TW:4153)
NT$30.85-0.45 (-1.44%)
TW:4153
Diva Laboratories, Ltd. financials statements
NT$30.85
At close:-0.45 (-1.44%)
Diva Laboratories, Ltd. (4153) Financial Statements
Diva Laboratories, Ltd. Financial Overview
Diva Laboratories, Ltd.'s market cap is currently NT$1.74B. The company's EPS TTM is NT$1.62; its P/E ratio is 15.93; and it has a dividend yield of 6.48%. Diva Laboratories, Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 868.84M | NT$ 862.32M | NT$ 893.84M | NT$ 949.20M | NT$ 712.23M |
| Gross Profit | NT$ 264.68M | NT$ 260.18M | NT$ 250.77M | NT$ 266.13M | NT$ 181.60M |
| Operating Income | NT$ 102.25M | NT$ 111.17M | NT$ 92.15M | NT$ 122.18M | NT$ 24.69M |
| EBITDA | NT$ 112.42M | NT$ 127.10M | NT$ 101.22M | NT$ 132.28M | NT$ 42.29M |
| Net Income | NT$ 90.54M | NT$ 93.66M | NT$ 73.62M | NT$ 49.66M | NT$ 21.86M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 494.10M | NT$ 589.14M | NT$ 541.29M | NT$ 346.37M | NT$ 300.22M |
| Total Assets | NT$ 1.35B | NT$ 1.31B | NT$ 1.24B | NT$ 1.25B | NT$ 1.18B |
| Total Debt | NT$ 2.90M | NT$ 4.97M | NT$ 7.50M | NT$ 283.00K | NT$ 411.00K |
| Net Debt | NT$ -491.13M | NT$ -584.17M | NT$ -529.42M | NT$ -346.08M | NT$ -298.86M |
| Total Liabilities | NT$ 324.52M | NT$ 249.94M | NT$ 210.93M | NT$ 235.62M | NT$ 195.27M |
| Stockholders' Equity | NT$ 1.03B | NT$ 1.06B | NT$ 1.03B | NT$ 1.02B | NT$ 986.42M |
| Cash Flow | |||||
| Free Cash Flow | NT$ 19.77M | NT$ 121.01M | NT$ 245.43M | NT$ 61.77M | NT$ -24.24M |
| Operating Cash Flow | NT$ 20.77M | NT$ 123.14M | NT$ 252.91M | NT$ 73.19M | NT$ -11.39M |
| Investing Cash Flow | NT$ 5.17M | NT$ 3.86M | NT$ -3.20M | NT$ -5.05M | NT$ 2.62M |
| Financing Cash Flow | NT$ -120.13M | NT$ -76.07M | NT$ -59.13M | NT$ -22.04M | NT$ -15.49M |
Currency in TWD
